Log in to save to my catalogue

RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase...

RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d6fa6ab33280410bb774cc7665f709dd

RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression

About this item

Full title

RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression

Publisher

England: BioMed Central Ltd

Journal title

Journal of experimental & clinical cancer research, 2018-08, Vol.37 (1), p.182-182, Article 182

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Human telomerase reverse transcriptase (hTERT) is highly expressed in over 80% of tumors, including human epithelial ovarian cancer (EOC). However, the mechanisms through which hTERT is up-regulated in EOC and promotes tumor progression remain unclear. The aim of this study is to identify RIF1 as a novel molecular target that modulate hTERT signali...

Alternative Titles

Full title

RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d6fa6ab33280410bb774cc7665f709dd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d6fa6ab33280410bb774cc7665f709dd

Other Identifiers

ISSN

1756-9966,0392-9078

E-ISSN

1756-9966

DOI

10.1186/s13046-018-0854-8

How to access this item